This week I’d like to discuss type 2 diabetes (T2D) and inflammation. Usually I try to follow topics sequentially, but I was reviewing an article about type 2 diabetes and inflammation and thought it was quite interesting. The results of a large trial (TECOS) were released in June 2015 and illustrates once again the futility of targeting blood sugars in the treatment of T2D. This got me thinking about T2D again. So apologies, but we’ll start this series in the middle of the story.
Sourced through Scoop.it from: intensivedietarymanagement.com